- CATIE NewsUntreated syphilis can cause many harms to adults and to fetuses during pregnancy. A Winnipeg study found that stillbirths related to syphilis rose sixfold over three years. Greater access to…
- The following list contains contact details for free formula programs in Canada for people living with HIV. If your region does not have a program specifically for people with HIV, there may be other…
- CATIE NewsBiktarvy is a widely used HIV treatment, however, it has not been well studied in pregnancy. Researchers monitored its use in 33 pregnant women living with HIV in Thailand. Levels of study drugs fell…
- Safety and effectiveness of long-acting cabotegravir for prevention in cisgender women
- CATIE NewsAn American study analysed blood and urine samples from women with and without HIV. Women with HIV were less likely to retain vitamin C in their bodies. The cause of the vitamin C loss was not clear…
- This guide provides information about menopause for women living with HIV who are at any stage of their menopause transition.
- CATIE NewsResearchers enrolled 1,422 women living with HIV from British Columbia, Ontario and Quebec. Those who face stigma and discrimination were less likely to take medication as prescribed. The researchers…
- A review of best practices to improve awareness of and access to PrEP for women at risk of HIV infection and barriers and facilitators to PrEP uptake.
- Prevention in FocusThis article looks at the rising rates of congenital syphilis in Canada and the role that service providers have in addressing congenital syphilis through prevention, testing and treatment services.
- Prevention in FocusThis article aims to help service providers become more self-reflective and sensitive to how gender shapes individuals' access, uptake and benefits of harm reduction services.
- Prevention in FocusAn overview of Canadian resources that service providers can use to understand and address harm reduction among women.
- Prevention in FocusAn overview of Canadian resources that service providers can use to understand and address HIV and hepatitis C among women.